info@seagull-health.com
SeagullHealth
语言:
search

Who can use Litfulo(Ritlecitinib)?

Ritlecitinib, an innovative kinase inhibitor, is specifically designed for adults and adolescents aged 12 years and older to effectively treat severe alopecia areata.

Ritlecitinib(Litfulo)
Ritlecitinib(Litfulo)
Adolescents aged 12 years and older, as well as adult patients, with alopecia...
WeChat Scan
Free Inquiry
Related articles
Indications for Ritlecitinib
Ritlecitinib is an innovative kinase inhibitor with precise target action, clear indication range, specific dosage and adverse reactions to be noted, which together constitute a comprehensive the...
Instructions for Ritlecitinib: action and efficacy, dosage, side effects, precautions
Ritlecitinib is an innovative oral kinase inhibitor that offers a new treatment option for patients with severe alopecia areata. This article will start from the instructions of Ritlecitinib ...
共 2 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved